Table 1 Patient characteristics
From: LY6K is a novel molecular target in bladder cancer on basis of integrate genome-wide profiling
Bladder cancer | |
Total number | 91 |
Median age (range) | 74 (46–100) years |
Stage | |
pTa | 20 |
pT1 | 27 |
pT2 | 20 |
pT3 | 6 |
pT4 | 4 |
Unknown | 14 |
Grade | |
G1 | 7 |
G2 | 41 |
G3 | 31 |
Unknown | 12 |
Normal bladder epithelium | |
Total number | 37 |
Median age (range) | 68 (32–77) years |
